NCT06742580

Brief Summary

In the etıology of Idıopathıc Acute Perıpheral Facıal Palsy, known as bell palsy, many causes have been descrıbed, such as specıfıc ımmune, ıchemıc, ınfectıous and heredıal factors. ın our study, we have observed the blood homocysteıne level that causes thrombotıc dısorders ın paralysıs patıents.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

December 13, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 19, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 4, 2025

Completed
Last Updated

December 19, 2024

Status Verified

December 1, 2024

Enrollment Period

1.3 years

First QC Date

December 13, 2024

Last Update Submit

December 18, 2024

Conditions

Keywords

Acute Peripheral Facial ParalysisHomocysteineBell Palsy

Outcome Measures

Primary Outcomes (1)

  • Homosystein test results

    The results have not been obtained from lab yet. So none results were measured .

    up to 24 weeks

Study Arms (2)

Bell palsy patient group

Patients who applied to our hospital due to idiopathic facial paralysis within the first month

control group

Healthy individuals with no known health problems

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

AFYON HEALTH SCIENCES UNIVERSITY HOSPITAL

You may qualify if:

  • \- Patients admitted with acute facial paralysis

You may not qualify if:

  • Facial and ear trauma or tumor
  • İatrogenic
  • Cholesteatoma
  • Facial paralysis due to central nervous system diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Afyonkarahisar Health Sciences University

Afyonkarahisar, Turkey (Türkiye)

ACTIVE NOT RECRUITING

Afyonkarahisar Health Sciences University

Afyonkarahisar, Turkey (Türkiye)

RECRUITING

Afyonkarahisar Health Sciences University

Afyonkarahisar, Turkey (Türkiye)

RECRUITING

Related Publications (4)

  • Singh A, Deshmukh P. Bell's Palsy: A Review. Cureus. 2022 Oct 11;14(10):e30186. doi: 10.7759/cureus.30186. eCollection 2022 Oct.

    PMID: 36397921BACKGROUND
  • Son P, Lewis L. Hyperhomocysteinemia. 2022 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554408/

    PMID: 32119295BACKGROUND
  • Niu X, Chen Y, Zhong Y, Xiao X. The relationship between serum homocysteine levels and sudden sensorineural hearing loss: a meta-analysis. Eur Arch Otorhinolaryngol. 2023 May;280(5):2091-2097. doi: 10.1007/s00405-023-07829-w. Epub 2023 Jan 19.

    PMID: 36658368BACKGROUND
  • Eviston TJ, Croxson GR, Kennedy PG, Hadlock T, Krishnan AV. Bell's palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1356-61. doi: 10.1136/jnnp-2014-309563. Epub 2015 Apr 9.

    PMID: 25857657BACKGROUND

MeSH Terms

Conditions

Facial ParalysisBell Palsy

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsFacial Nerve DiseasesCranial Nerve Diseases

Study Officials

  • Orhan Kemal KAHVECİ, PROFESSOR

    AFYON HEALTH SCIENCES UNIVERSITY HOSPITAL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MURAT AKIN, ASSISTANT DOCTOR

CONTACT

Orhan Kemal KAHVECİ, PROFESSOR

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assistant doctor

Study Record Dates

First Submitted

December 13, 2024

First Posted

December 19, 2024

Study Start

December 1, 2023

Primary Completion

April 1, 2025

Study Completion

August 4, 2025

Last Updated

December 19, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

WILL BE DECLARED AT THE RESULT OF THE STUDY

Locations